qPCR was performed using the 7900 Sequence Detection System ( Applied Biosystems ), with the following gene - specific primers: phosphoglycerate kinase 1 ( PGK1, forward: 5 ′- ctgctgttccaagcatcaaa - 3 ′ reverse: 5 ′- gcatcttttcccttcccttc - 3 ′), glial fibrillary acidic protein ( GFAP, forward: 5 ′- acgcttctccttgtctcgaa - 3 ′ reverse: 5 ′- cggcgatagtcgttagcttc - 3 ′), ionized calcium binding adapter molecule 1 ( Iba1, forward: 5 ′- atgagccaaagcagggattt - 3 ′ reverse: 5 ′- gaccagttggcctcttgtgt - 3 ′), NOD - like receptor family, pyrin domain containing 3 ( NLRP3, forward: 5 ′- ccttggaccaggttcagtgt - 3 ′ reverse: 5 ′- aggagatgtcgaagcagcat - 3 ′), purinergic receptor P2X ligand - gated ion channel 7 ( P2X7R, forward: 5 ′- tgtgtgcattgacttgctca - 3 ′ reverse: 5 ′- cttgcagacttttcccaagc - 3 ′) Interleukin - 1 beta ( IL - 1β, forward: 5 ′- gaccttccaggatgaggaca - 3 ′ reverse: 5 ′- aggccacaggtattttgtcg - 3 ′).	"phosphoglycerate kinase 1	128	153	Gene/Protein"	"PGK1	156	160	Gene/Protein"	"glial fibrillary acidic protein	246	277	Gene/Protein"	"GFAP	280	284	Gene/Protein"	"ionized calcium binding adapter molecule 1	370	412	Gene/Protein"	"Iba1	415	419	Gene/Protein"	"NLRP3	561	566	Gene/Protein"	"purinergic receptor P2X ligand - gated ion channel 7	652	704	Gene/Protein"	"P2X7R	707	712	Gene/Protein"	"Interleukin - 1 beta	797	817	Gene/Protein"	"IL - 1β	820	827	Gene/Protein"	"[{""token"": ""phosphoglycerate kinase 1"", ""start_span"": 128, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""PGK1"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""glial fibrillary acidic protein"", ""start_span"": 246, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""GFAP"", ""start_span"": 280, ""end_span"": 284, ""type"": ""Gene/Protein""}, {""token"": ""ionized calcium binding adapter molecule 1"", ""start_span"": 370, ""end_span"": 412, ""type"": ""Gene/Protein""}, {""token"": ""Iba1"", ""start_span"": 415, ""end_span"": 419, ""type"": ""Gene/Protein""}, {""token"": ""NLRP3"", ""start_span"": 561, ""end_span"": 566, ""type"": ""Gene/Protein""}, {""token"": ""purinergic receptor P2X ligand - gated ion channel 7"", ""start_span"": 652, ""end_span"": 704, ""type"": ""Gene/Protein""}, {""token"": ""P2X7R"", ""start_span"": 707, ""end_span"": 712, ""type"": ""Gene/Protein""}, {""token"": ""Interleukin - 1 beta"", ""start_span"": 797, ""end_span"": 817, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 820, ""end_span"": 827, ""type"": ""Gene/Protein""}]"
Of note, whilst HZ and PHN are associated with higher costs to healthcare providers in elderly populations, costs to society in terms of time missed for work tends to be lower, so the total costs overall are similar across age groups [ 60 ]. Table 5 Mean total cost of management per HZ or PHN case Country Population age Cost per case HZ PHN1 * PHN3 ^ Belgium [ 26] Aged ≥ 50 € 118 ( no pain )€ 156. 94 ( mild pain )€ 329. 22 ( mild pain )€ 1, 150. 50 ( severe pain )€ 1, 085. 60 ( severe pain )€ 2, 037. 86 ( severe pain) France [ 30] Aged ≥ 50 € 419. 87 ( 271 – 586 )€ 672. 76 ( 451 – 968 )- Germany [ 31] Aged ≥ 50 € 388. 30 ( 354 – 425 )-€ 1, 427. 80 ( 1, 002 - 1, 917) Germany [ 67] Aged ≥ 50 € 729. 57 € 2, 167. 89Italy [ 29] Aged ≥ 50 € 888. 06 -€ 1, 66. 65Spain [ 27] Aged > 14 Overall: € 446. 04 ( SD 508. 58 )€ 647. 82 ( SD 684. 4 )€ 968. 78 ( SD 803. 58) 50 - 59: € 282. 06 ( SD 273. 15) 60 - 69 :€ 510. 52 ( SD 512. 73) > 70: € 422. 91 ( SD 388. 66) Spain [ 69] Aged > 30 € 460. 95 € 1, 956. 15 - Sweden [ 63] All ages € 902. 88 ( HZ and PHN) Switzerland [ 72] Aged ≥ 50 € 394. 46 ( no pain )-€ 381. 15 ( no pain )€ 1, 835. 57 ( severe pain )€ 2, 442. 99 ( severe pain) UK [ 7] Not specified € 793. 60 ( 31 – 6, 394 )--( all ages) Aged + 65: € 788. 48 * PHN defined as pain persisting for one month following resolution of HZ rash .^ PHN defined as pain persisting for three months following resolution of HZ rash.	"HZ	16	18	Disease/Disorder"	"PHN	23	26	Disease/Disorder"	"HZ	284	286	Disease/Disorder"	"PHN	290	293	Disease/Disorder"	"HZ	336	338	Disease/Disorder"	"HZ	1044	1046	Disease/Disorder"	"PHN	1051	1054	Disease/Disorder"	"PHN	1267	1270	Disease/Disorder"	"HZ	1336	1338	Disease/Disorder"	"PHN	1347	1350	Disease/Disorder"	"HZ	1419	1421	Disease/Disorder"	"[{""token"": ""HZ"", ""start_span"": 16, ""end_span"": 18, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 284, ""end_span"": 286, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 290, ""end_span"": 293, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 336, ""end_span"": 338, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 1044, ""end_span"": 1046, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 1051, ""end_span"": 1054, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 1267, ""end_span"": 1270, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 1336, ""end_span"": 1338, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 1347, ""end_span"": 1350, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 1419, ""end_span"": 1421, ""type"": ""Disease/Disorder""}]"
The expression levels of some genes that encode ROS - scavenging enzymes, e. g ., cytosolic ascorbate peroxidase1 ( cAPX1 ), ascorbate peroxidase2 ( APX2 ), and Fe superoxide dismutase ( FSD1 ), increased in the P7 - 1 - OE anthers about 2 - fold higher than in wild - type, but the levels of ROS - producing related genes, e. g ., respiratory burst oxidase homolog A ( RBOHA) and respiratory burst oxidase homolog B ( RBOHB ), were reduced in the transgenic anthers compared with the wild type ( Figure 6C ).	"cytosolic ascorbate peroxidase1	82	113	Gene/Protein"	"cAPX1	116	121	Gene/Protein"	"ascorbate peroxidase2	125	146	Gene/Protein"	"APX2	149	153	Gene/Protein"	"Fe superoxide dismutase	161	184	Gene/Protein"	"FSD1	187	191	Gene/Protein"	"P7 - 1	212	218	Gene/Protein"	"respiratory burst oxidase homolog A	332	367	Gene/Protein"	"RBOHA	370	375	Gene/Protein"	"respiratory burst oxidase homolog B	381	416	Gene/Protein"	"RBOHB	419	424	Gene/Protein"	"[{""token"": ""cytosolic ascorbate peroxidase1"", ""start_span"": 82, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""cAPX1"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""ascorbate peroxidase2"", ""start_span"": 125, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""APX2"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""Fe superoxide dismutase"", ""start_span"": 161, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""FSD1"", ""start_span"": 187, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""P7 - 1"", ""start_span"": 212, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""respiratory burst oxidase homolog A"", ""start_span"": 332, ""end_span"": 367, ""type"": ""Gene/Protein""}, {""token"": ""RBOHA"", ""start_span"": 370, ""end_span"": 375, ""type"": ""Gene/Protein""}, {""token"": ""respiratory burst oxidase homolog B"", ""start_span"": 381, ""end_span"": 416, ""type"": ""Gene/Protein""}, {""token"": ""RBOHB"", ""start_span"": 419, ""end_span"": 424, ""type"": ""Gene/Protein""}]"
Here, we showed that the transcriptional levels of the lignin biosynthesis genes 4CL, CCoAOMT, and C3H were reduced in the flowers of RBSDV P7 - 1 transgenic plants compared with the flowers of wild - type plants ( Figure 5 ), although the expression levels of CCR1, CAD c, and CAD d were unchanged in the transgenic plants ( data not shown ).	"4CL	81	84	Gene/Protein"	"CCoAOMT	86	93	Gene/Protein"	"C3H	99	102	Gene/Protein"	"RBSDV	134	139	Organism/Species"	"P7 - 1	140	146	Gene/Protein"	"plants	158	164	Organism/Species"	"plants	206	212	Organism/Species"	"CCR1	261	265	Gene/Protein"	"CAD c	267	272	Gene/Protein"	"CAD d	278	283	Gene/Protein"	"plants	317	323	Organism/Species"	"[{""token"": ""4CL"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""CCoAOMT"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""C3H"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""RBSDV"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Organism/Species""}, {""token"": ""P7 - 1"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 158, ""end_span"": 164, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 206, ""end_span"": 212, ""type"": ""Organism/Species""}, {""token"": ""CCR1"", ""start_span"": 261, ""end_span"": 265, ""type"": ""Gene/Protein""}, {""token"": ""CAD c"", ""start_span"": 267, ""end_span"": 272, ""type"": ""Gene/Protein""}, {""token"": ""CAD d"", ""start_span"": 278, ""end_span"": 283, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 317, ""end_span"": 323, ""type"": ""Organism/Species""}]"
Expression levels of 7 immune checkpoint molecules ( PD - 1, CTLA - 4, LAG - 3, TIGIT, TIM - 3, CD160 and 2B4) as well as 4 markers of HIV persistence ( integrated and total HIV DNA, 2 - LTR circles and cell - associated unspliced HIV RNA) were measured in PBMCs from 48 virally suppressed individuals.	"immune checkpoint molecules	23	50	Gene/Protein"	"PD - 1	53	59	Gene/Protein"	"CTLA - 4	61	69	Gene/Protein"	"LAG - 3	71	78	Gene/Protein"	"TIGIT	80	85	Gene/Protein"	"TIM - 3	87	94	Gene/Protein"	"CD160	96	101	Gene/Protein"	"2B4	106	109	Gene/Protein"	"HIV	135	138	Organism/Species"	"HIV	174	177	Organism/Species"	"HIV	231	234	Organism/Species"	"[{""token"": ""immune checkpoint molecules"", ""start_span"": 23, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""CTLA - 4"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""TIM - 3"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""CD160"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""2B4"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 231, ""end_span"": 234, ""type"": ""Organism/Species""}]"
The same antibody backbone was used in the two panels: CD3 - Alexa700 ( clone UCHT1, BD # 557943 ), CD4 - QDot605 ( clone S3. 5, Invitrogen # Q10008 ), CD8 - PB ( clone RPA - T8, BD # 558207 ), CD14 - V500 ( clone M5E2, BD # 561391 ), CD19 - AmCyan ( clone SJ25C1, BD # 339190 ), LIVE / DEAD Aqua marker ( Invitrogen # L34957 ), CD45RA - APC - H7 ( clone HI100, BD # 560674 ), CD27 - BV650 ( clone O323, Biolegend # 302828) and CCR7 - PE - Cy7 ( clone 3D12, BD # 557648 ).	"antibody	9	17	Gene/Protein"	"CD3	55	58	Gene/Protein"	"CD4	100	103	Gene/Protein"	"Q10008	142	148	Chemical/Drug"	"CD8	152	155	Gene/Protein"	"CD14	194	198	Gene/Protein"	"CD19	235	239	Gene/Protein"	"CD45RA	329	335	Gene/Protein"	"CD27	377	381	Gene/Protein"	"CCR7	428	432	Gene/Protein"	"PE	435	437	Gene/Protein"	"[{""token"": ""antibody"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""Q10008"", ""start_span"": 142, ""end_span"": 148, ""type"": ""Chemical/Drug""}, {""token"": ""CD8"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 235, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""CD45RA"", ""start_span"": 329, ""end_span"": 335, ""type"": ""Gene/Protein""}, {""token"": ""CD27"", ""start_span"": 377, ""end_span"": 381, ""type"": ""Gene/Protein""}, {""token"": ""CCR7"", ""start_span"": 428, ""end_span"": 432, ""type"": ""Gene/Protein""}, {""token"": ""PE"", ""start_span"": 435, ""end_span"": 437, ""type"": ""Gene/Protein""}]"
Primer sets were designed to differentiate and quantitate the following major anaerobic genera – Bacteroides, Clostridium, Campylobacter, Bifidobacterium, Ruminococcus, Eubacterium, Lactobacillus, Methanobrevibacter and Sulfate - reducing bacteria ( SRB ). 16S rRNA gene was targeted for designing primers except for SRB ( Table 1 ).	"Bacteroides	97	108	Organism/Species"	"Clostridium	110	121	Organism/Species"	"Campylobacter	123	136	Organism/Species"	"Bifidobacterium	138	153	Organism/Species"	"Ruminococcus	155	167	Organism/Species"	"Eubacterium	169	180	Organism/Species"	"Lactobacillus	182	195	Organism/Species"	"Methanobrevibacter	197	215	Organism/Species"	"Sulfate - reducing bacteria	220	247	Organism/Species"	"SRB	250	253	Organism/Species"	"SRB	317	320	Organism/Species"	"[{""token"": ""Bacteroides"", ""start_span"": 97, ""end_span"": 108, ""type"": ""Organism/Species""}, {""token"": ""Clostridium"", ""start_span"": 110, ""end_span"": 121, ""type"": ""Organism/Species""}, {""token"": ""Campylobacter"", ""start_span"": 123, ""end_span"": 136, ""type"": ""Organism/Species""}, {""token"": ""Bifidobacterium"", ""start_span"": 138, ""end_span"": 153, ""type"": ""Organism/Species""}, {""token"": ""Ruminococcus"", ""start_span"": 155, ""end_span"": 167, ""type"": ""Organism/Species""}, {""token"": ""Eubacterium"", ""start_span"": 169, ""end_span"": 180, ""type"": ""Organism/Species""}, {""token"": ""Lactobacillus"", ""start_span"": 182, ""end_span"": 195, ""type"": ""Organism/Species""}, {""token"": ""Methanobrevibacter"", ""start_span"": 197, ""end_span"": 215, ""type"": ""Organism/Species""}, {""token"": ""Sulfate - reducing bacteria"", ""start_span"": 220, ""end_span"": 247, ""type"": ""Organism/Species""}, {""token"": ""SRB"", ""start_span"": 250, ""end_span"": 253, ""type"": ""Organism/Species""}, {""token"": ""SRB"", ""start_span"": 317, ""end_span"": 320, ""type"": ""Organism/Species""}]"
High quality DNA isolated from E. histolytica positive stool sample was subjected to Real Time analysis to assess the predominant gut flora that included Bacteroides, Bifidobacterium, Eubacterium, Clostridium leptum subgroup, Clostridium coccoides subgroup, Lactobacillus and Ruminococcus. Two subdominant genera Methanobrevibacter smithii and Sulphur reducing bacteria ( SRB) were also quantified.	"gut flora	130	139	Organism/Species"	"Bacteroides	154	165	Organism/Species"	"Bifidobacterium	167	182	Organism/Species"	"Eubacterium	184	195	Organism/Species"	"Clostridium leptum	197	215	Organism/Species"	"Clostridium coccoides	226	247	Organism/Species"	"Lactobacillus	258	271	Organism/Species"	"Ruminococcus	276	288	Organism/Species"	"Methanobrevibacter smithii	313	339	Organism/Species"	"Sulphur reducing bacteria	344	369	Organism/Species"	"SRB	372	375	Organism/Species"	"[{""token"": ""gut flora"", ""start_span"": 130, ""end_span"": 139, ""type"": ""Organism/Species""}, {""token"": ""Bacteroides"", ""start_span"": 154, ""end_span"": 165, ""type"": ""Organism/Species""}, {""token"": ""Bifidobacterium"", ""start_span"": 167, ""end_span"": 182, ""type"": ""Organism/Species""}, {""token"": ""Eubacterium"", ""start_span"": 184, ""end_span"": 195, ""type"": ""Organism/Species""}, {""token"": ""Clostridium leptum"", ""start_span"": 197, ""end_span"": 215, ""type"": ""Organism/Species""}, {""token"": ""Clostridium coccoides"", ""start_span"": 226, ""end_span"": 247, ""type"": ""Organism/Species""}, {""token"": ""Lactobacillus"", ""start_span"": 258, ""end_span"": 271, ""type"": ""Organism/Species""}, {""token"": ""Ruminococcus"", ""start_span"": 276, ""end_span"": 288, ""type"": ""Organism/Species""}, {""token"": ""Methanobrevibacter smithii"", ""start_span"": 313, ""end_span"": 339, ""type"": ""Organism/Species""}, {""token"": ""Sulphur reducing bacteria"", ""start_span"": 344, ""end_span"": 369, ""type"": ""Organism/Species""}, {""token"": ""SRB"", ""start_span"": 372, ""end_span"": 375, ""type"": ""Organism/Species""}]"
Monoclonal rat anti - mouse antibodies against CD29, CD44, CD45, and CD11b were from BD Biosciences; and rabbit anti - mouse inducible nitric oxide synthase ( iNOS) and CD206 monoclonal antibodies were from Abcam.	"rat	11	14	Organism/Species"	"mouse	22	27	Organism/Species"	"CD29	47	51	Gene/Protein"	"CD44	53	57	Gene/Protein"	"CD45	59	63	Gene/Protein"	"CD11b	69	74	Gene/Protein"	"rabbit	105	111	Organism/Species"	"mouse	119	124	Organism/Species"	"nitric oxide synthase	135	156	Gene/Protein"	"iNOS	159	163	Gene/Protein"	"CD206	169	174	Gene/Protein"	"[{""token"": ""rat"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Organism/Species""}, {""token"": ""CD29"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""CD44"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""CD45"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Organism/Species""}, {""token"": ""nitric oxide synthase"", ""start_span"": 135, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""iNOS"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""CD206"", ""start_span"": 169, ""end_span"": 174, ""type"": ""Gene/Protein""}]"
The human breast carcinoma MDA - MB - 231 - FLUC cells, human HCC - LM3 - FLUC hepatoma cells, human U87MG - FLUC glioma cells and murine 4T1 - FLUC breast cancer cells were stably transfected with a lentiviral vector containing a firefly luciferase reporter gene were first selected in vitro, and then injected into immune - deficient or normal mice.	"human	4	9	Organism/Species"	"breast carcinoma	10	26	Disease/Disorder"	"human	56	61	Organism/Species"	"hepatoma	79	87	Disease/Disorder"	"human	95	100	Organism/Species"	"glioma	114	120	Disease/Disorder"	"murine	131	137	Organism/Species"	"breast cancer	149	162	Disease/Disorder"	"firefly	231	238	Organism/Species"	"luciferase	239	249	Gene/Protein"	"mice	346	350	Organism/Species"	"[{""token"": ""human"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Organism/Species""}, {""token"": ""breast carcinoma"", ""start_span"": 10, ""end_span"": 26, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Organism/Species""}, {""token"": ""hepatoma"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Organism/Species""}, {""token"": ""glioma"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Disease/Disorder""}, {""token"": ""murine"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Organism/Species""}, {""token"": ""breast cancer"", ""start_span"": 149, ""end_span"": 162, ""type"": ""Disease/Disorder""}, {""token"": ""firefly"", ""start_span"": 231, ""end_span"": 238, ""type"": ""Organism/Species""}, {""token"": ""luciferase"", ""start_span"": 239, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 346, ""end_span"": 350, ""type"": ""Organism/Species""}]"
